Visual hallucinations associated with Parkinson disease

Archives of Neurology
J R Sanchez-RamosG W Paulson

Abstract

To determine factors that are predictive for the development of hallucinations associated with Parkinson disease (PD). Hallucinations are a common difficulty for patients with established PD, and hallucinations and psychosis may be the most common causes for nursing home placement. The characteristics of the hallucinations associated with PD differ from the hallucinations associated with schizophrenia or cocaine abuse. Multiple factors have been suggested as causal. A total of 214 consecutive patients were interviewed during routine visits to the Parkinson's Disease Clinics in Columbus, Ohio, and Miami, Fla, using a hallucination questionnaire, Folstein Mini-Mental State Examination, and an attempt to correlate age, duration of disease, medication, and psychological or sleep disorders with the hallucinations. Hallucinations were almost exclusively visual and were present in 55 of the 214 patients. Dementia, age, duration of disease, history of depression, or history of sleep disorder were strongly associated with the hallucinations. While reduction in levodopa and anticholinergic medication doses is appropriate in the management of hallucinations, the factors that predispose patients to hallucinations include dementia and advan...Continue Reading

Citations

Jan 28, 2014·Current Treatment Options in Neurology·Jennifer G Goldman, Samantha Holden
Oct 29, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·J M GrahamH J Sagar
Jun 1, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·J Barnes, A S David
Jun 1, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·S HolroydG F Wooten
Nov 13, 2003·Postgraduate Medical Journal·B R ThanviT C N Lo
Oct 8, 2005·Postgraduate Medical Journal·B R ThanviD P Harsh
Jun 24, 2008·BMC Neurology·Spiridon PapapetropoulosBonnie Levin
Jul 31, 2008·Drugs & Aging·Laura B Zahodne, Hubert H Fernandez
Aug 7, 2010·Dementia and Geriatric Cognitive Disorders·Heather KatzenBonnie Levin
May 10, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Gilles FénelonAnne-Catherine Bachoud-Lévi
May 24, 2011·Parkinson's Disease·Ariane Park, Mark Stacy
Jan 10, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Kelly Bertram, David R Williams
Mar 15, 2013·Neuropsychiatric Disease and Treatment·David J Pedrosa, Lars Timmermann
Dec 21, 2000·Current Psychiatry Reports·C Ballard, M Walker
Jun 7, 2005·Current Psychiatry Reports·Dominic H Ffytche
Mar 20, 2012·Acta neurologica Belgica·Marina SvetelVladimir Kostić
Jun 5, 2002·Current Neurology and Neuroscience Reports·Karen E Anderson, William J Weiner
Mar 20, 2002·Current Neurology and Neuroscience Reports·E S Molho, S A Factor
Apr 2, 2011·Acta Neuropathologica·Manuel F CasanovaKurt A Jellinger
Sep 5, 2001·Neurologic Clinics·G Glosser
Sep 29, 2000·Parkinsonism & Related Disorders·A A Rabinstein, L M Shulman
May 4, 2004·Parkinsonism & Related Disorders·Babak Tousi, Mark Frankel
Nov 30, 1999·Acta Neurologica Scandinavica·E KraftD P Auer
Feb 25, 2005·Journal of Neurology·Christian BaumannClaudio Lino Bassetti
Apr 19, 2005·Journal of Neurology·Spiridon PapapetropoulosJohn Ellul
Jul 7, 2005·Journal of Neurology·Spiridon Papapetropoulos, D C Mash
Sep 29, 2006·Journal of Neurology·Thomas Benke
Apr 3, 2007·Journal of Neurology·Günes KiziltanEthem Erginöz
Jun 22, 2011·Journal of Neurology·Paulo BugalhoBernardo Neto
Dec 11, 2003·Current Treatment Options in Neurology·Victoria S. Pelak, Grant T. Liu
Sep 17, 2011·Brain : a Journal of Neurology·David A GallagherAnette Schrag
Nov 6, 2007·Internal Medicine·Hideaki MatsuiFukashi Udaka
Oct 18, 2008·International Review of Psychiatry·Doron Merims, Morris Freedman
Dec 7, 2007·Expert Review of Neurotherapeutics·Marco OnofrjLaura Bonanni
Jun 4, 2011·Expert Opinion on Pharmacotherapy·Jennifer G GoldmanChristopher G Goetz
Mar 22, 2006·Expert Opinion on Investigational Drugs·Kelvin L Chou, Hubert H Fernandez
Dec 10, 2015·Expert Opinion on Drug Safety·Roberto CeravoloUbaldo Bonuccelli
Dec 3, 2008·Expert Opinion on Emerging Drugs·Karl Strecker, Johannes Schwarz
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Lisa SkipperEng-King Tan
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
May 3, 2007·Expert Opinion on Pharmacotherapy·Kelvin L ChouJoseph H Friedman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Pharmacotherapy
James J Gugger, Mary L Wagner
Movement Disorders : Official Journal of the Movement Disorder Society
R DjaldettiE Melamed
Movement Disorders : Official Journal of the Movement Disorder Society
C G GoetzSue Leurgans
© 2021 Meta ULC. All rights reserved